Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development

Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent GlioblastomaABINGDON, OXFORDSHIRE / ACCESSWIRE / June 1, 2022 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), an R&D biotechnology company focused on improving the …